Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Controlled Clinical Trial Comparing Comprehensive Radiotherapy Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer

NCT07015138 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07015138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07015138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Controlled Clinical Trial Comparing Comprehensive Radiotherapy Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2027
Enrollment
390 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic prostate cancer, prostate cancer